Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single‐Dose Crossover Studies in Healthy Japanese Men-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single‐Dose Crossover Studies in Healthy Japanese Men

Published:2022-03-21 Issue:8 Volume:11 Page:957-965
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharm in Drug Dev

Author:

Kurata Akifumi¹,Eto Takashi²,Tsutsumi Junko³,Igawa Yoshiyuki¹,Nishikawa Yasuhiro⁴,Ishizuka Hitoshi¹

Affiliation:

1. Quantitative Clinical Pharmacology Department Daiichi Sankyo Co., Ltd. Tokyo Japan

2. Souseikai Hakata Clinic Fukuoka Japan

3. Data Intelligence Department Daiichi Sankyo Co., Ltd. Tokyo Japan

4. Development Strategy & Planning Group Daiichi Sankyo Co., Ltd. Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1087

Reference31 articles.

1. Viewpoint on Guidelines for Treatment of Hypertension in Japan

2. Prevention and Control of Hypertension

3. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines

4. Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs to Improve Swallowing Experience

5. Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease;Kidney Diseases;2022-11-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3